Insider Transactions by Sablich Kim

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
JAZZJazz Pharmaceuticals plcSablich KimEVP, GM of U.S.Jun 05, 2023Option Exercise$129.732,082270,09828,478Jun 07, 2023, 07:15 PM
JAZZJazz Pharmaceuticals plcSablich KimEVP, GM of U.S., Commercial MaMar 08, 2023Sale$139.743,013421,04331,821Mar 10, 2023, 06:10 PM
JAZZJazz Pharmaceuticals plcSablich KimEVP, GM of U.S., Commercial MaMar 05, 2023Option Exercise$142.781,610229,87633,573Mar 07, 2023, 08:50 PM
JAZZJazz Pharmaceuticals plcSablich KimEVP & GM, North AmericaJun 06, 2022Option Exercise$150.533,147473,71528,583Jun 08, 2022, 04:56 PM
JAZZJazz Pharmaceuticals plcSablich KimEVP & GM, North AmericaJun 07, 2022Sale$151.052,441368,71326,995Jun 08, 2022, 04:56 PM
JAZZJazz Pharmaceuticals plcSablich KimEVP & GM, North AmericaMar 05, 2022Option Exercise$153.96746114,85430,342Mar 09, 2022, 06:05 PM
JAZZJazz Pharmaceuticals plcSablich KimEVP & GM, North AmericaNov 11, 2021Sale$135.012,748370,99921,135Nov 15, 2021, 07:30 PM
JAZZJazz Pharmaceuticals plcSablich KimEVP & GM, North AmericaJun 05, 2021Option Exercise$176.471,452256,23423,883Jun 09, 2021, 06:55 PM
MYOVMyovant Sciences Ltd.Sablich KimChief Commercial OfficerMar 18, 2020Sale$7.377855,78758,920Mar 19, 2020, 04:32 PM
MYOVMyovant Sciences Ltd.Sablich KimChief Commercial OfficerJan 15, 2020Sale$14.044,84067,95459,690Jan 16, 2020, 05:28 PM
MYOVMyovant Sciences Ltd.Sablich KimChief Commercial OfficerDec 18, 2019Sale$16.222,58541,92964,530Dec 19, 2019, 04:25 PM